Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling-Wen Ding

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cancers|November 14, 2023
MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific SignaturesGideon Ze Lin Tan, Sai Mun Leong, Yu Jin, et al.
Oncogene|July 8, 2018
ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancerXiao Guo, Yin Zhang, Anand Mayakonda, et al.
Cancer Research|April 17, 2015
Genomic and Functional Analysis of the E3 Ligase PARK2 in GliomaDe-Chen Lin, Liang Xu, Ye Chen, et al.
Cancer Research|January 6, 2021
A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal AdenocarcinomaSai Ma, Bo Zhou, Qian Yang, et al.
Advanced Healthcare Materials|February 17, 2026
Golgi Apparatus-Targeting Immunostimulant for Synergistic Activation of Antitumor Immunity via Pyroptosis Induction and PD-L1 DegradationRong-Rong Zheng, Qiu-Yuan Li, Shui-Ying Zhang, et al.
Cancer Research|September 28, 2017
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal CarcinomaJiang Yuan, Yan-Yi Jiang, Anand Mayakonda, et al.
ACS Applied Materials & Interfaces|September 25, 2025
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 UpregulationYi Cen, Xin-Xuan Li, Ying Chen, et al.
Molecular Oncology|February 1, 2015
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancerWenwen Chien, Qiao-Yang Sun, Kian Leong Lee, et al.
BMC Cancer|October 5, 2018
Profiling the B/T cell receptor repertoire of lymphocyte derived cell linesKar-Tong Tan, Ling-Wen Ding, Qiao-Yang Sun, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cancers|November 14, 2023
MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific SignaturesGideon Ze Lin Tan, Sai Mun Leong, Yu Jin, et al.
Oncogene|July 8, 2018
ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancerXiao Guo, Yin Zhang, Anand Mayakonda, et al.
Cancer Research|April 17, 2015
Genomic and Functional Analysis of the E3 Ligase PARK2 in GliomaDe-Chen Lin, Liang Xu, Ye Chen, et al.
Cancer Research|January 6, 2021
A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal AdenocarcinomaSai Ma, Bo Zhou, Qian Yang, et al.
Advanced Healthcare Materials|February 17, 2026
Golgi Apparatus-Targeting Immunostimulant for Synergistic Activation of Antitumor Immunity via Pyroptosis Induction and PD-L1 DegradationRong-Rong Zheng, Qiu-Yuan Li, Shui-Ying Zhang, et al.
Cancer Research|September 28, 2017
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal CarcinomaJiang Yuan, Yan-Yi Jiang, Anand Mayakonda, et al.
ACS Applied Materials & Interfaces|September 25, 2025
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 UpregulationYi Cen, Xin-Xuan Li, Ying Chen, et al.
Molecular Oncology|February 1, 2015
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancerWenwen Chien, Qiao-Yang Sun, Kian Leong Lee, et al.
BMC Cancer|October 5, 2018
Profiling the B/T cell receptor repertoire of lymphocyte derived cell linesKar-Tong Tan, Ling-Wen Ding, Qiao-Yang Sun, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Pageof 6